SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | n/a |
Enterprise Value ($M) | n/a |
Book Value ($M) | 2,795.57 |
Book Value / Share | 42.42 |
Price / Book | n/a |
NCAV ($M) | 2,299.76 |
NCAV / Share | 34.90 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.08 |
Return on Assets (ROA) | 0.04 |
Return on Equity (ROE) | 0.08 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 8.84 |
Current Ratio | 9.02 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 3,861.59 |
Assets | 4,357.40 |
Liabilities | 1,561.83 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 239.72 |
Operating Income | -88.26 |
Net Income | 211.70 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -405.97 |
Cash from Investing | 71.19 |
Cash from Financing | -5.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | EcoR1 Capital, LLC | 9.90 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
47,353 | 269,304 | 17.58 | |
9,875 | 22,193 | 44.50 | |
6,360 | 66,331 | 9.59 | |
18,965 | 103,475 | 18.33 | |
(click for more detail) |
Similar Companies | |
---|---|
ABCL – AbCellera Biologics Inc. | ABOS – Acumen Pharmaceuticals, Inc. |
ABUS – Arbutus Biopharma Corporation | ACAD – ACADIA Pharmaceuticals Inc. |
ACLX – Arcellx, Inc. |
Financial data and stock pages provided by
Fintel.io